-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RJCmLOdhy5R6GGsykgMPvBMMr2thheVhfl5xxIHTnKWOC3ZkCY9l8Tlbj9uqSdKu kQKTP5LeEhjyRal7QUgiXw== 0001010192-98-000010.txt : 19980218 0001010192-98-000010.hdr.sgml : 19980218 ACCESSION NUMBER: 0001010192-98-000010 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980213 SROS: NYSE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LONGS DRUG STORES CORP CENTRAL INDEX KEY: 0000764762 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 680048627 STATE OF INCORPORATION: MD FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-37157 FILM NUMBER: 98537279 BUSINESS ADDRESS: STREET 1: 141 N CIVIC DR CITY: WALNUT CREEK STATE: CA ZIP: 94596 BUSINESS PHONE: 4159371170 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PLANS POLICY COMMITTEE OF LONGS DRUG STORES CA EMPL PFT CENTRAL INDEX KEY: 0000939935 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 141 NORTH CIVIC DRIVE CITY: WALNUT CREEK STATE: CA ZIP: 94596 BUSINESS PHONE: 4159371170 MAIL ADDRESS: STREET 1: 141 NORTH CIVIC DRIVE CITY: WALNUT CREEK STATE: CA ZIP: 94596 SC 13G/A 1 LONGS DRUG STORES CORPORATIONB- AMENDMENT 17 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 17 )* Longs Drug Stores Corporation ----------------------------------------------------- (Name of Issuer) Common Stock ----------------------------------------------------- (Title of Class of Securities) 543162101 ----------------------------------------------------- (CUSIP Number) Check the following box if a fee is being paid with this statement [ ]. - ---------- *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 543162101 13G Page 2 of 5 Pages - -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON(S) S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON(S) Plans Policy Committee of Longs Drugs California Inc. Employee Profit Sharing plan # 94-1059121 - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* Not Applicable (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION USA - -------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER -0- SHARES BENEFICIALLY -------------------------------------------------------------- OWNED BY 6. SHARED VOTING POWER -0- EACH REPORTING -------------------------------------------------------------- PERSON 7. SOLE DISPOSITIVE POWER -0- WITH -------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER 7,524,387 - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 19.48% - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! 13G Page 3 of 5 Pages Item 1. (a) Name of Issuer: Longs Drug Stores Corporation -------------------------------------------------------------- (b) Address of Issuer's Principal Executive Offices: P.O. Box 5222 Walnut Creek, CA 94596 -------------------------------------------------------------- Item 2. (a) Name of Person Filing: Plans Policy Committee of Longs Drugs California Inc. Employee Profit Sharing plan -------------------------------------------------------------- (b) Address of Principal Business Office, or if None, Residence: P.O. Box 5222 Walnut Creek, CA 94596 -------------------------------------------------------------- (c) Citizenship: U.S.A. ------------------------------------------------- (d) Title of Class of Securities: Common Stock -------------------------------------------------------------- (e) CUSIP Number: 543162101 ------------------------------------------------- Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) [ ] Broker or Dealer registered under Section 15 of the Act, (b) [ ] Bank as defined in Section 3(a)(6) of the Act, (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act, (d) [ ] Investment Company registered under Section 8 of the Investment Company Act, (e) [ ] Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940, (f) [x] Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see Section 240.13d-1(b)(ii)(F); see Item 7, (g) [ ] Parent Holding Company, in accordance with Section 240.13d-1(b)(1)(ii)(G); see Item 7, (h) [ ] Group, in accordance with Section 240.13d-1(b)(1)(ii)(H). 13-G Page 4 of 5 Pages Item 4. Ownership. If more than five percent of the class is owned, indicate: (a) Amount beneficially owned: 7,524,387 -------------------------------------, (b) Percent of class: 19.48% ----------------------------------------------, (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote -0- -----------------, (ii) Shared power to vote or to direct the vote -0- --------------, (iii) Sole power to dispose or to direct the disposition of -0- -------------------------------------------------------, (iv) Shared power to dispose or to direct the disposition of 7,524.387 -------------------------------------------------- Item 5. Ownership of Five Percent or Less of a Class. Not Applicable Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Not Applicable Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable Item 10. Certification. Not Applicable The filing of this schedule shall not be construed as an admission that the reporting person is the beneficial owner of the following securities: 7,524,387 shares held by the Plan for Plan participants. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 2, 1998 Ronald ???? Signature ___________________________________________ Chairman, Plans Policy Committee Longs Drug Stores California, Inc. Employee Profit Sharing Plan -----END PRIVACY-ENHANCED MESSAGE-----